"Prothrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
| Descriptor ID |
D011517
|
| MeSH Number(s) |
E01.370.225.625.115.610 E05.200.625.115.610 G09.188.680
|
| Concept/Terms |
Prothrombin Time- Prothrombin Time
- Prothrombin Times
- Time, Prothrombin
- Times, Prothrombin
|
Below are MeSH descriptors whose meaning is more general than "Prothrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Prothrombin Time".
This graph shows the total number of publications written about "Prothrombin Time" by people in this website by year, and whether "Prothrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prothrombin Time" by people in Profiles.
-
Controversies in anticoagulation therapy in patients with cirrhosis. Curr Opin Gastroenterol. 2019 05; 35(3):161-167.
-
Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother. 2011 Nov; 45(11):1433-8.
-
Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009 Mar; 17(3):183-96.
-
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion. 2005 Aug; 45(8):1362-72.
-
Use of aprotinin during cardiopulmonary bypass in a patient with protein C deficiency. J Extra Corpor Technol. 2003 Mar; 35(1):39-43.
-
Thromboembolic risk factors in patients undergoing kidney transplant: implication of abnormally short activated partial thromboplastin time. Ann Clin Lab Sci. 2003; 33(4):396-400.
-
Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation. 2002 Jun 15; 73(11):1717-23.
-
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Circulation. 2002 May 21; 105(20):2385-91.
-
Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop Relat Res. 1997 Dec; (345):174-80.
-
Indianapolis hospitals standardize changes in prothrombin time testing. Indiana Med. 1995 Mar-Apr; 88(2):136-8.